Category: anti-viral

Could Magnolia Tree Bark Rival Vaccines in the Fight Against COVID-19?

Researchers in the Netherlands have uncovered that honokiol, a compound found in the bark of magnolia trees, has the capacity to stop the spread of the SARS-CoV-2 virus within the body. The study, published on May 22 in Microbiology Spectrum, an esteemed publication of the American Society for Microbiology, offers an innovative approach to the…


Merck’s Antiviral COVID-19 Pill Approved in Singapore

Singapore has approved a second oral antiviral drug for treating COVID-19. Molnupiravir, branded as Lagevrio, was granted interim authorization under the Pandemic Special Access Route (PSAR) by the Health Sciences Authority (HSA) on April 19. The medicine was approved for treating mild to moderate COVID-19 patients aged 18 and above, who are at risk of…


Roche Looking for New Place to Test COVID-19 Pill After Cases Plummet in UK

ZURICH—Roche is looking for another location to carry out trials of its pill to fight COVID-19, after plummeting case numbers in Britain made it difficult to find enough patients for its study there, the Swiss drugmaker said on Wednesday. Roche and Boston-based partner Atea Pharmaceuticals are hoping their AT-527 pill could offer an anti-viral therapy…